Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Munich, Germany, Tuesday 2 September 2008: Heart failure is a leading cause of death and hospitalisation and represents a major burden on health services. It is estimated that over 15 million people in Europe suffer from heart failure and the syndrome accounts for over 2% of national expenditure on health. The new guidelines on heart failure from the European Society of Cardiology are eagerly awaited.
The guidelines are developed through a rigorous process involving a task force of 15 experts in the field and a review committee of 21 international authorities.The 2008 ESC guidelines cover for the first time both acute and chronic heart failure. Indeed, the guidelines have built upon the realisation that patients with acute heart failure often develop chronic problems and likewise, those with chronic heart failure, often suffer from acute illness.The paper reviews diagnostic techniques, both pharmaceutical and device therapy, as well as non-pharmacological management. Unlike past guidelines, the 2008 document sees greater emphasis placed on the importance of implementing treatment recommendations and management of palliative care. The document also summarises the major "gaps in evidence" in an attempt to focus future clinical research on important issues that have not been adequately addressed. As such, the paper addresses issues that cardiologists are aware of, but do not have evidence for.The 2008 guidelines will be launched at the ESC congress in Munich on September 1. The full text will be published simultaneously in the European Heart Journal and the European Journal of Heart Failure in September. This document is important and largely determines treatment strategy for the most common clinical problem in medicine in the 51 countries in greater Europe. Readers can look forward to a user-friendly document, written in straightforward language thus making for an enjoyable read.
This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2008. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology.
© 2017 European Society of Cardiology. All rights reserved